title: Pressure group urges rosuvastatin recall.
authors.forename: Alicia
authors.initials: A
authors.lastname: Ault
mesh_terms: D000328:Adult; D026683:Advisory Committees; D004335:Drug and Narcotic Control; D005260:Female; D005464:Fluorobenzenes / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000139:chemically induced; D012206:Rhabdomyolysis / Q000139:chemically induced; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium